Moret C, Pastrie I, Briley M
Department of Biochemical Pharmacology, Centre de Recherche Pierre Fabre, Castre, France.
Methods Find Exp Clin Pharmacol. 1988 Oct;10(10):619-21.
3H-Quinuclidinyl benzylate (3H-QNB) and 3H-cis-methyldioxolane (3H-CD) binding to cholinergic muscarinic receptors have been carried out on the same membrane preparation from the rat brain cortex. Inhibition of 3H-QNB and 3H-CD binding by cholinergic muscarinic agonists and antagonists has been studied with determination of the IC50 values for each ligand. Antagonists were as potent at inhibiting 3H-QNB binding as 3H-CD binding. Muscarinic agonists were much less potent at inhibiting 3H-QNB binding than 3H-CD binding. The ratio of the IC50 values for the inhibition of the binding of 3H-QNB and 3H-CD was between 1 and 10 for antagonists and between 500 and 5000 for agonists. It is suggested that the determination of this ratio predicts agonist or antagonist activity of unknown compounds and represents a useful tool for their screening.
已在来自大鼠大脑皮层的同一膜制剂上进行了3H-奎宁环基苯甲酸酯(3H-QNB)和3H-顺式甲基二氧戊环(3H-CD)与胆碱能毒蕈碱受体的结合实验。通过测定每种配体的IC50值,研究了胆碱能毒蕈碱激动剂和拮抗剂对3H-QNB和3H-CD结合的抑制作用。拮抗剂在抑制3H-QNB结合方面与抑制3H-CD结合的效力相当。毒蕈碱激动剂在抑制3H-QNB结合方面的效力远低于抑制3H-CD结合。对于拮抗剂,抑制3H-QNB和3H-CD结合的IC50值之比在1至10之间,而对于激动剂则在500至5000之间。有人提出,该比值的测定可预测未知化合物的激动剂或拮抗剂活性,并代表一种用于筛选它们的有用工具。